Injectable cosmetic products not permitted under law, says drug regulator CDSCO

India's central drug regulator has clarified that injectable cosmetic products are not considered cosmetics under the law, aiming to prevent misuse and ensure consumer safety.

Injectable cosmetic products not permitted under law, says drug regulator CDSCO
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

Cosmetic products supplied in injectable form do not fall under the definition of cosmetics under the law and are not permitted for use by consumers, professionals or aesthetic clinics, the central drug regulator has made it clear.

The advisory by the Central Drugs Standard Control Organisation's (CDSCO) comes amid the growing popularity of injectable aesthetic procedures being promoted as ''cosmetic'' treatments in beauty clinics and wellness centres across the country.

The clarification is aimed at preventing misuse of cosmetic products for treatment purposes and ensuring consumer safety, particularly as non-surgical aesthetic procedures gain popularity in urban centres and through social media promotion, a source said.

The move also seeks to curb misleading advertising and unauthorised cosmetic practices by clinics and individuals.

In the public notice issued on May 18, the regulator said that cosmetics are intended only to be ''rubbed, poured, sprinkled or sprayed'' on the body for cleansing, beautifying, promoting attractiveness or altering appearance.

''Products supplied in form of injectable preparation do not fall under the definition of cosmetics. No cosmetic is permitted to be used as injection by consumer/professionals/ aesthetic clinics,'' the notice said.

The regulator also warned against misleading claims and the use of prohibited ingredients in cosmetic products, saying such violations attract action under the Drugs and Cosmetics Act and Cosmetics Rules, 2020.

The CDSCO further said cosmetics are permitted only for their intended use and cannot be used for treatment purposes by professionals or individuals.

The notice added that the list of generally not recognised as safe (GNRAS) and restricted ingredients is published by the Bureau of Indian Standards (BIS).

The public has been encouraged to report violations or misleading practices to the regulatory authority through email or state licensing authorities, the notice added.

TRENDING

OPINION / BLOG / INTERVIEW

Workers see AI as helpful, but fear losing credit for their own expertise

GPTs, chatbots and machine learning drive new wave of AI clinical trial records

Universities face new sustainability test: Turning SDG talk into institutional action

Antimicrobial resistance has ancient roots, but its public health threat is growing now

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback